CRO Celerion Expands to SingaporeBy
The contract research organization Celerion has established a business presence in Singapore, lead by Dr. Chew Lan Chong, who has been appointed as executive director, medical research. He will lead Celerion's business operations in Singapore, provide medical and scientific expertise, and collaborate with partner early-clinical research units to conduct early-clinical pharmacology studies.
The opening of the Singapore operations and appointment of Dr. Chong follows Celerion's expansion into South Korea. Celerion recently announced the opening of clinical operations at Seoul National University Hospital Clinical Trial Center and a collaboration with the Korean Drug Development Fund.
Celerion is headquartered in Lincoln, Nebraska, and in addition to Lincoln, has facilities in, Neptune, New Jersey; Tempe, Arizona; West Conshohocken, Pennsylvania; Montreal, Canada; Belfast, Northern Ireland; and Fehraltorf, Switzerland.